Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss of $1.13/sh

Go back to Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss of $1.13/sh
(NASDAQ: VRDN) Delayed: 22.88 --0 (-0%)
Previous Close $22.88    52 Week High
Open $22.88    52 Week Low
Day High $22.88    P/E N/A 
Day Low $22.88    EPS
Volume 43